Nope. Norman Swan interviewed on ABC RN Breakfast talks about Covid Nasal vaccines and blockers. Views. I am closely watching the state of the World Economy, particularly China and the U. SPL. We know that they haven't been marketed well but i think BigPharma have had an input. Application for quotation of securities - SPL. Comments. ASX - By Stock. m. Share Interesting points John Some institutions might accept anything over $1. Talk with one of our capital. 1029/9/2000 SPL $0. So the Scripps evidence of efficacy will be the main basis for the decision. I hope I'm wrong here. Click for more information. Latest Posts. Created with Sketch. ASX - By Stock. 57% 13. This will make for sad reading. Forums. 0. You should withdraw the statement. BCSPL – VI Wave. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. ca/pst. , page-4. ASX - Day TradingSo ton of quistions to answer for CEO and Board most of them already posed so does she follow past format by putting out an update today that she can. Last updated 10. DJPIN. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. Last updated 15. The matter has been adjourned to. 30. This product was expected to produce rivers of. They need IMO to define good and any other qualifying words !!. 19/09/23. ASX - General. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Hey, "smart", I concur with your message. Join the. ASX - General. . Change in substantial holding. Charts. 75. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. ASX - Short Term Trading. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. Enter the title of your abstract. The ASX is trying to crack down on many companies. ASX - By Stock. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. The thread is titled so that it can be found and general enough so as to. Share I sometimes wonder if they actually work at Starpharma. Volume. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. 74. Latest Posts. . Charts. Created with Sketch. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). . Last updated 15. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 1 Introduction. I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. 0%. 0¢. Merck -- 2. J K Fairley $1,272,084N J Baade. ”For your information 55% of the company is held by institutions” ~ AB I. Market . Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. SPL Price at posting: 71. I saw that some director etc invested there own money in the SPP etc,. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. Since then. SPL. 3¢. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. most else of the list is same as we want to happen years ago and long long overdue. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. 88. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. 22/9/2000 CSL $11. ASX - Short Term Trading. Created with Sketch. Latest Posts. Commodities. S. Latest Posts. ASX - By Stock. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. 49M. 5¢. ASX - By Stock. And he still is Chairman or Director of SIX other companies. Hope that SPL starts to deliver on its promises. 0¢. SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology. 8¢. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. 62). ASX - General. 0¢. SPL. Some links within this article worth a scan too. 00%. . SPL Price at posting: 14. 76. 0000. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 63. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. Become a member of Australia's largest investment discussion forum. But SPL is different, isn't it? SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Imo, financial things such as deals, sales and. 7¢. They not even have a license with SPL, just a basic research agreement. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". . Created with Sketch. " Indeed. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. Market Cap $5. . 2. 12. ASX - Day Trading. 68. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. . DISCOVER THE BATTERY METALS REVOLUTION. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. 3¢. Slow golf clap for Jackie Fairley. Starpharma was 96 cents in April 2002. Created with Sketch. Created with Sketch. Last updated 15. . SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. FORTESCUE METALS GROUP LTD. . Become a member of Australia's largest investment discussion forum. Market . . I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. Starpharma is listed on the Australian stock exchange (ASX:SPL). Click for more information. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Latest Posts. Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). LEADING THE BATTERY METALS REVOLUTION. 45K. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Advertise. 58pm 20/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. Share Interesting and positive early pre-clinical results. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. 13. Charts. Perhaps they will today tomorrow. More. Market Cap $58. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. And somebody must be buying all the shares that are being sold. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. 4¢. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 57. The Company is. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Target our investor community with our. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Join the HotCopper ASX share market forum today for free. 00. 0¢. ASX - Short Term Trading. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. Last updated 15. ASX - Day Trading. 5¢. ” This, sadly, is not true. 0¢. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. StarPharma Holdings Ltd. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Well done SPL and Scripps Institute. New Zealand Dollar. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. Canadian Dollar. 5 cents. Surely the political restraints. 129294. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. Market . granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. 15667. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. Working in a. International Markets. . Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. . 6. 00%. So on the one hand you state SPL isn't a nasal spray company. 1dB. ASX - Day Trading SUBMISSION STEPS. July 31 (Reuters) - Starpharma Holdings Ltd (SPL) : ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT OF AZD0466, AFTER AN INTERNAL REVIEW. A correctly formatted example follows: Title of my presentation for the conference. . 0¢. Join the HotCopper ASX share market forum today for free. 83453. 2:00 am Eastern Standard Time Australia. $-0. Share It would be silly to be tight on cash. HotCopper is Australia's largest free and independent stock market trading forum for. Forums. . ASX - By Stock. and as I said I met @Domesticgod there, which was a pleasure. Join the HotCopper ASX share market forum today for free. Don’t look to him for the truth lol. Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. municipal. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. In March 2020 the SPL share price dropped to a low of 0. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. Join the HotCopper ASX. 6. As of 2015, HotCopper was in the top 170 websites in Australia and was. 0012. Twelve month SPL daily chartSame old trend continues. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Cristal therapeutics. Advertise on HotCopper. 43M. Latest Posts. Join the HotCopper ASX share market forum today for free. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. ROFL. Some links within this article worth a scan too. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day TradingCreated with Sketch. ACCELERATE RESOURCES LIMITED. ASX - By Stock. ASX - Day Trading. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Above $20m revenue, SPL rakes in zero R&D tax refunds until revenue becomes high enough for SPL to actually make a profit. . A sad state of affairs IMO. Last updated 15. Last updated 15. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - By Stock. ASX - Day Trading. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). There is potentially a multi-bagger upside if there was an exceptionally good news announcement. LEADING THE BATTERY METALS REVOLUTION. . Unusual to make that announcement?. $-0. , page-3. Market Cap $. SPL. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. Imo HotCopper posters must have an. 4. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. . The recent announcement about Viraleze nasal. SPL scientists will no doubt be working on this right now. Market. . All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP. 0¢. . SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. Join the HotCopper ASX share market forum today for free. Hey, "smart", I concur with your message. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Time to put your feet up and kick back for a while. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 9¢. NEW YORK TRANSN DEV CORP SPL FAC REV 4. SPL Price at posting: 16. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. , page-2. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. 6% downward extention down to (0. 48. Created with Sketch. 59pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. 1. AX8. NSX - By Stock. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. IMO they haven't . Application for quotation of securities - SPL. Build your trading strategy and connect with. Target our investor community with our. ASX - Day Trading So the share price of SPL rose up to a high of $2. Is this a case of short memories? The best one can say is her surprise is disingenuous. However, just a word of caution before the usual pumping starts by the usual suspects. Forums. . Created with Sketch. Volume. Created with Sketch. ASX - Short. ASX - By Stock. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . Eight (8) contributors to the HC SPL thread made price predictions (thank. Forums. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. Their IP doesn't last forever - you need to hustle in pharma. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. StarPharma Holdings Ltd. 0. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. . Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat.